EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results and Highlights Recent Corporate Developments

Go back to EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results and Highlights Recent Corporate Developments
(NASDAQ: EYPT) Delayed: 14.38 +0.65 (4.73%)
Previous Close $13.73    52 Week High
Open $13.62    52 Week Low
Day High $14.88    P/E N/A 
Day Low $13.61    EPS
Volume 1,551,516